| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |